Join BioModels’ Scientists, Andrew Borkowski, PhD and Nicole Smith, PhD, as they discuss a selection of key preclinical models of inflammatory disease.
Predominantly inflammation driven diseases like acute lung injury, asthma, Crohn’s Disease, Ulcerative Colitis and Graft vs Host Disease (GvHD) impact a large and diverse patient population and present a major opportunity for innovation in drug discovery. In this webinar, Drs. Andrew Borkowski and Nicole Smith discuss preclinical models, including models of Inflammatory Bowel Disease (IBD)/colitis, GvHD, and pulmonary disease, focusing on the utility of clinically relevant endpoints that create highly translational models of human disease.
Key Topics Include:
- Learn about translational and predictive animal models of Inflammatory Bowel Disease (IBD), Graft versus Host Disease (GVHD), and pulmonary disease
- Understand the basic components of a successful and comprehensive study design in these therapeutic areas
- Review the typical disease induction approach, disease kinetics, responses to standard of care therapies, and standard endpoints/outcomes that are assessed in these models
- Understand how you can work with BioModels to support your drug development efforts using either established disease models or validating new models and endpoints
- Categories: Drug Discovery & Development, Microbiology & Immunology, Respiratory Science
- Tags: animal model development, animal models, asthma, colitis, graft vs host disease, GVHD, IBS, inflammatory disease, irritable bowel syndrome, lung disease, pulmonary disease
Presenters
Andrew Borkowski, PhD
Principal Scientist
Biomodels
Dr. Borkowski joined Biomodels in 2017 and has diverse interests in the field of immunology and currently works on inflammatory, fibrotic, and pulmonary disease models.
Nicole Smith, PhD
Senior Scientist II
Biomodels
Dr. Smith joined Biomodels in 2017 and is interested in model development and diverse pre-clinical indications, currently focusing on IBD, arthritis, and mucositis.
Production Partner
Biomodels, LLC
Biomodels, is an AAALAC accredited preclinical CRO that develops and executes predictive and highly translational efficacy studies for biotech and pharma companies in a variety of indications. We understand the importance of providing personalized service, innovative solutions and clinically relevant disease models.
Additional Content From Scientist.com
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.
